Kidney in Heart Failure (eBook)
XIV, 250 Seiten
Springer US (Verlag)
978-1-4614-3694-2 (ISBN)
Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death. The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management.
The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart. This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management. In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are included. Each chapter is co-authored by a Nephrologist and Cardiologist, offering a unified perspective to these chronic conditions.
This indispensible volume provides the reader with the depth-of-knowledge needed for assessing and treating the cardio renal patient.
Dr. Bakris is currently Professor of Medicine and Director of the Hypertension Center at the University of Chicago Pritzker School of Medicine. Dr. Bakris has published over 600 articles and book chapters in the areas of diabetic kidney disease, hypertension and progression of nephropathy. He is the Editor or Co-Editor of eight books, in the areas of Kidney Disease Progression and Diabetes. Additionally, he is the Associate Editor of the International Textbook of Cardiology. He chaired the first National Kidney Foundation Consensus report on blood pressure and impact on renal disease progression (2000). He has also served on many national guideline committees including: JNC VI and 7 writing committees, the JNC 7 executive committee, the American Diabetes Association Clinical Practice Guideline Committee. Dr. Bakris is also the past-president of the American College of Clinical Pharmacology and the current President of the American Society of Hypertension (ASH) (2010-2012). He is the current Editor of American Journal of Nephrology and Hypertension, Section Editor of Up-to-Date and Associate Editor of Diabetes Care and Nephrology, Dialysis & Transplant.
Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death. The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management. The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart. This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management. In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are included. Each chapter is co-authored by a Nephrologist and Cardiologist, offering a unified perspective to these chronic conditions. This indispensible volume provides the reader with the depth-of-knowledge needed for assessing and treating the cardio renal patient.
Dr. Bakris is currently Professor of Medicine and Director of the Hypertension Center at the University of Chicago Pritzker School of Medicine. Dr. Bakris has published over 600 articles and book chapters in the areas of diabetic kidney disease, hypertension and progression of nephropathy. He is the Editor or Co-Editor of eight books, in the areas of Kidney Disease Progression and Diabetes. Additionally, he is the Associate Editor of the International Textbook of Cardiology. He chaired the first National Kidney Foundation Consensus report on blood pressure and impact on renal disease progression (2000). He has also served on many national guideline committees including: JNC VI and 7 writing committees, the JNC 7 executive committee, the American Diabetes Association Clinical Practice Guideline Committee. Dr. Bakris is also the past-president of the American College of Clinical Pharmacology and the current President of the American Society of Hypertension (ASH) (2010-2012). He is the current Editor of American Journal of Nephrology and Hypertension, Section Editor of Up-to-Date and Associate Editor of Diabetes Care and Nephrology, Dialysis & Transplant.
Foreword Peter A. McCulloughPrefacePart One EpidemiologyChapter 1 Epidemiology of Chronic Kidney Disease in Heart Failure Ruth C. Campbell and Ali Ahmed Chapter 2 Anemia and Cardiovascular Risk in the Kidney Disease Patients: What is the best way to achieve and what is the desired hemoglobin? Tejas V. Patel and Ajay K. Singh Part Two PathophysiologyChapter 3 Renal Hemodynamic Changes in Heart Failure Ivana Lazich and George L. BakrisChapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade Mohammed Shakaib and George L. BakrisChapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient Biff F. PalmerChapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications Ivan D. Hanson and Peter A. McCullough Part Three Management of Kidney Associated Clinical ProblemsChapter 7 Hyperkalemia Risk and Treatment of Heart Failure Julian Segura and Luis M. RuilopeChapter 8 Management of Heart Failure with Renal Artery Ischaemia Andrew K. Roy and Patrick MurrayChapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure Eric M. Brown, Daniel J. Salzberg, Matthew R. WeirChapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. SicaChapter 11 Ultrafiltration and Heart Failure Paul Chacko, Donald Kikta Jr., William T. Abraham Part Four Advances in Nephropathy Management: Influences on CVD RiskChapter 12 Combination Therapy in Hypertension Treatment Raymond V. Oliva and George L. BakrisChapter 13 Medication Adherence in Heart Failure Daniel E. Hilleman and Jennifer A. CampbellChapter 14 New Markers of Vascular Risk David Davidson and Michael H. DavidsonChapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD Raghu V. Durvasula and Katherine R. TuttlePrefacePart One EpidemiologyChapter 1 Epidemiology of Chronic Kidney Disease in Heart Failure Ruth C. Campbell and Ali Ahmed Chapter 2 Anemia and Cardiovascular Risk in the Kidney Disease Patients: What is the best way to achieve and what is the desired hemoglobin? Tejas V. Patel and Ajay K. Singh Part Two PathophysiologyChapter 3 Renal Hemodynamic Changes in Heart Failure Ivana Lazich and George L. BakrisChapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade Mohammed Shakaib and George L. BakrisChapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient Biff F. PalmerChapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications Ivan D. Hanson and Peter A. McCullough Part Three Management of Kidney Associated Clinical ProblemsChapter 7 Hyperkalemia Risk and Treatment of Heart Failure Julian Segura and Luis M. RuilopeChapter 8 Management of Heart Failure with Renal Artery Ischaemia Andrew K. Roy and Patrick MurrayChapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure Eric M. Brown, Daniel J. Salzberg, Matthew R. WeirChapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. SicaChapter 11 Ultrafiltration and Heart Failure Paul Chacko, Donald Kikta Jr., William T. Abraham Part Four Advances in Nephropathy Management: Influences on CVD RiskChapter 12 Combination Therapy in Hypertension Treatment Raymond V. Oliva and George L. BakrisChapter 13 Medication Adherence in Heart Failure Daniel E. Hilleman and Jennifer A. CampbellChapter 14 New Markers of Vascular Risk David Davidson and Michael H. DavidsonChapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD Raghu V. Durvasula and Katherine R. Tuttle Ivana Lazich and George L. BakrisChapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade Mohammed Shakaib and George L. BakrisChapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient Biff F. PalmerChapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications Ivan D. Hanson and Peter A. McCullough Part Three Management of Kidney Associated Clinical ProblemsChapter 7 Hyperkalemia Risk and Treatment of Heart Failure Julian Segura and Luis M. RuilopeChapter 8 Management of Heart Failure with Renal Artery Ischaemia Andrew K. Roy and Patrick MurrayChapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure Eric M. Brown, Daniel J. Salzberg, Matthew R. WeirChapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. SicaChapter 11 Ultrafiltration and Heart Failure Paul Chacko, Donald Kikta Jr., William T. Abraham Part Four Advances in Nephropathy Management: Influences on CVD RiskChapter 12 Combination Therapy in Hypertension Treatment Raymond V. Oliva and George L. BakrisChapter 13 Medication Adherence in Heart Failure Daniel E. Hilleman and Jennifer A. CampbellChapter 14 New Markers of Vascular Risk David Davidson and Michael H. DavidsonChapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD Raghu V. Durvasula and Katherine R. Tuttle Mohammed Shakaib and George L. BakrisChapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient Biff F. PalmerChapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications Ivan D. Hanson and Peter A. McCullough Part Three Management of Kidney Associated Clinical ProblemsChapter 7 Hyperkalemia Risk and Treatment of Heart Failure Julian Segura and Luis M. RuilopeChapter 8 Management of Heart Failure with Renal Artery Ischaemia Andrew K. Roy and Patrick MurrayChapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure Eric M. Brown, Daniel J. Salzberg, Matthew R. WeirChapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. SicaChapter 11 Ultrafiltration and Heart Failure Paul Chacko, Donald Kikta Jr., William T. Abraham Part Four Advances in Nephropathy Management: Influences on CVD RiskChapter 12 Combination Therapy in Hypertension Treatment Raymond V. Oliva and George L. BakrisChapter 13 Medication Adherence in Heart Failure Daniel E. Hilleman and Jennifer A. CampbellChapter 14 New Markers of Vascular Risk David Davidson and Michael H. DavidsonChapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD Raghu V. Durvasula and Katherine R. Tuttle
| Erscheint lt. Verlag | 10.7.2012 |
|---|---|
| Zusatzinfo | XIV, 250 p. |
| Verlagsort | New York |
| Sprache | englisch |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie |
| Medizinische Fachgebiete ► Innere Medizin ► Nephrologie | |
| Sozialwissenschaften ► Politik / Verwaltung | |
| Schlagworte | anemia • Diabetes • Heart Failure • Kidney Disease |
| ISBN-10 | 1-4614-3694-X / 146143694X |
| ISBN-13 | 978-1-4614-3694-2 / 9781461436942 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 3,5 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
